Recombinant human interferon beta-1a (DrugBank: Interferon beta-1a, Human interferon beta, Interferon beta)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
26 | HTLV-1-associated myelopathy | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00001785 (ClinicalTrials.gov) | September 1998 | 3/11/1999 | Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM) | Combined Virological and Immunological Evaluation of Treatment of Patients With Early HTLV-1-Associated Myelopathy With Recombinant Human Interferon Beta-1a | HTLV-I Infection;Spinal Cord Disease;Tropical Spastic Paraparesis | Drug: Recombinant human interferon beta-1a | National Institute of Neurological Disorders and Stroke (NINDS) | NULL | Completed | N/A | N/A | Both | 12 | Phase 2 | United States |